V. Berdoukas

P. Moraitis, G. Chouliaras, V. Ladis, 2009, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

Cardiac iron overload in sickle‐cell disease

A. Meloni, T. Coates, J. Wood, 2014, American journal of hematology.

Correction of X-Linked Lymphoproliferative Disease by Transplantation of Cord-Blood Stem Cells

E. Gluckman, D. Purtilo, D. Thierry, 1993 .

Cardiac Iron Overload In Sickle-Cell Disease

M. Lombardi, T. Coates, J. Wood, 2013 .

Impact of magnetic resonance imaging on cardiac mortality in thalassemia major

A. Kattamis, G. Chouliaras, C. Fragodimitri, 2011, Journal of magnetic resonance imaging : JMRI.

Survival in a large cohort of Greek patients with transfusion‐dependent beta thalassaemia and mortality ratios compared to the general population

A. Kattamis, G. Chouliaras, C. Fragodimitri, 2011, European journal of haematology.

Combining two orally active iron chelators for thalassemia

T. Coates, J. Wood, S. Carson, 2010, Annals of Hematology.

Iron chelation in thalassemia: time to reconsider our comfort zones

T. Coates, J. Wood, V. Berdoukas, 2011, Expert review of hematology.

In search of the optimal iron chelation therapy for patients with thalassemia major

V. Berdoukas, J. Wood, 2011, Haematologica.

The treatment of iron overload — psychiatric implications

P. Waldmeier, V. Berdoukas, M. Struck, 1993 .

The Clinical Approach to Thalassaemia

B. Modell, V. Berdoukas, B. Modell, 1984 .

Tissue iron evaluation in chronically transfused children shows significant levels of iron loading at a very young age

T. Coates, J. Wood, S. Carson, 2013, American journal of hematology.

Prevention of Cardiomyopathy in Transfusion-Dependent Homozygous Thalassaemia Today and the Role of Cardiac Magnetic Resonance Imaging

M. Tsironi, A. Aessopos, V. Berdoukas, 2009, Advances in hematology.

Bone‐marrow transplantation for thalassaemia

V. Berdoukas, P. Lam-po-tang, M. Vowels, 1986, The Medical journal of Australia.

Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload

R. Sposto, T. Coates, J. Wood, 2014, American journal of hematology.

Toxicity of oral iron chelator L1

P. Bentley, Heiner Frost, V. Berdoukas, 1993, The Lancet.

C. Yiannoutsos, G. Chouliaras, V. Ladis, 2009, European journal of haematology.

Brief report: correction of X-linked lymphoproliferative disease by transplantation of cord-blood stem cells.

E. Gluckman, D. Purtilo, D. Thierry, 1993, The New England journal of medicine.

Safety and efficacy of early start of iron chelation therapy with deferiprone in young children newly diagnosed with transfusion‐dependent thalassemia: A randomized controlled trial

F. Tricta, Mohsen Saleh Elalfy, H. Awad, 2018, American journal of hematology.

Rhodotorulic acid--investigation of its potential as an iron-chelating drug.

J. Graziano, A. Cerami, C. Peterson, 1979, The Journal of pharmacology and experimental therapeutics.

Antenatal diagnosis of thalassaemia major.

J. Clegg, D. Weatherall, B. Alter, 1978, British medical journal.

Urinary iron excretion for evaluating iron chelation efficacy in children with thalassemia major.

P. Wahidiyat, M. Yosia, I. Timan, 2019, Blood cells, molecules & diseases.

The heart in transfusion dependent homozygous thalassaemia today – prediction, prevention and management

M. Tsironi, A. Aessopos, V. Berdoukas, 2007, European journal of haematology.

Liver iron depletion and toxicity of the iron chelator Deferiprone (L, CP20) in the guinea pig

J. Papadimitriou, G. Kontoghiorghes, V. Berdoukas, 1997, Biometals.

Antinuclear antibodies in patients taking L1

V. Berdoukas, 1991, The Lancet.

Sustained normalization of cardiac function by chelation therapy in thalassaemia major.

I. Murray, R. Giles, A. Freeman, 1989, Clinical and laboratory haematology.

Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion

Juliano Lara Fernandes, Nelson Hamerschlak, A. Araújo, 2013, Revista brasileira de hematologia e hemoterapia.

Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit

P. Moraitis, C. Kattamis, G. Chouliaras, 2010, European journal of haematology.

A Randomized Trial on the Safety and Efficacy of Early Start of Iron Chelation Therapy with Deferiprone in Newly Diagnosed Children with Transfusion Dependent Thalassemia

F. Tricta, Mohsen Saleh Elalfy, A. Adly, 2016 .

Transfusion‐dependent thalassaemia: a new era

B. Modell, V. Berdoukas, 2008, The Medical journal of Australia.

Homozygous beta‐thalassaemia in a part‐Aboriginal Australian

B. H. Webster, V. Berdoukas, M. Vowels, 1983, The Medical journal of Australia.

Comparison of biventricular dimensions and function between pediatric sickle‐cell disease and thalassemia major patients without cardiac iron

M. Lombardi, A. Meloni, J. Detterich, 2013, American journal of hematology.

Rapid iron loading in heart and liver in a patient with transfusion dependent thalassaemia after brief poor compliance with iron chelation therapy.

S. Daar, V. Berdoukas, Saeed Ahmed, 2010, Sultan Qaboos University medical journal.

Rapid iron loading in a pregnant woman with transfusion-dependent thalassemia after brief cessation of iron chelation therapy

E. Gotsis, Ioanna Tzoumari, V. Berdoukas, 2008, European journal of haematology.

Community‐initiated screening programme for beta‐thalassaemia trait

V. Berdoukas, B. Raddatz, Boyd H Webster, 1983, The Medical journal of Australia.

Glucose Phosphate Isomerase Deficiency In 2 Patients With Novel Mutations Presenting As Severe Neurologic Abnormalities and Transfusion Dependent Hemolytic Anemia

T. Coates, B. Glader, P. Gallagher, 2013 .

New golden era of chelation therapy in thalassaemia: the achievement and maintenance of normal range body iron stores. Response to Kontoghiorghes et al

G. Chouliaras, Ioanna Tzoumari, V. Berdoukas, 2010 .

Survival in a large cohort of Greek patients with transfusion‐dependent beta thalassaemia and mortality ratios compared to the general population

A. Kattamis, G. Chouliaras, C. Fragodimitri, 2011, European journal of haematology.

Comparison of biventricular dimensions and function between pediatric sickle‐cell disease and thalassemia major patients without cardiac iron

M. Lombardi, A. Meloni, J. Detterich, 2013, American journal of hematology.

Journal of Cardiovascular Magnetic Resonance Open Access the Efficacy of Iron Chelator Regimes in Reducing Cardiac and Hepatic Iron in Patients with Thalassaemia Major: a Clinical Observational Study

P. Moraitis, G. Chouliaras, V. Ladis, 2009 .